Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Profit per Employee

The Profit per Employee of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Nov 12, 2026 is 48,812.71 CNY. In the previous year, Profit per Employee was 43,032.64 CNY — a change of 13.43% (higher).

Profit per Employee

48,812.71CNY

YoY

13.43%

Last updated:

Profit per Employee of Vcanbio Cell & Gene Engineering Corp is 2025 48,812.71 CNY. Profit per Employee of Vcanbio Cell & Gene Engineering Corp was 2024 43,032.64 CNY. It decreases by 13.43% higher compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
25,408.62 CNY
Jan 1, 2019
21,309.95 CNY
Jan 1, 2020
-54,401.50 CNY
Jan 1, 2021
66,603.81 CNY
Jan 1, 2022
48,450.54 CNY
Jan 1, 2023
45,648.66 CNY
Jan 1, 2024
43,032.64 CNY
Jan 1, 2025
48,812.71 CNY
The Vcanbio Cell & Gene Engineering Corp Profit per Employee history
YEARProfit per EmployeeYoY
48,812.71CNY+13.43%
43,032.64CNY-5.73%
45,648.66CNY-5.78%
48,450.54CNY-27.26%
66,603.81CNY-222.43%
-54,401.50CNY-355.29%
21,309.95CNY-16.13%
25,408.62CNY+471.58%
4,445.34CNY-72.62%
16,234.96CNY-81.83%
89,345.25CNY+487.49%
15,207.97CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp., Ltd. generates revenue through the development and sale of life sciences technology products. The company produces cytokines culture solutions, cosmetics, and detection reagents for domestic markets. Its business segments include cell culture, gene detection and storage, and the production of specialized biological products. The firm's domestic customers primarily purchase these products for research and commercial applications in the life sciences sector. Vcanbio focuses on cell culture and gene detection services, which are integral to its product offerings. The company's cytokines culture solutions are sold to domestic clients in the biotechnology and pharmaceutical industries. Detection reagents are also marketed to domestic laboratories and healthcare providers for diagnostic purposes. The firm leverages its 2,332 full-time employees to support research, development, and production activities. The company's product portfolio includes cosmetics alongside scientific reagents, targeting both consumer and professional markets. Domestic markets remain the primary focus for all sales, with no mention of international operations. Vcanbio's revenue streams are derived from the sale of its core products, which are developed and manufactured in-house. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Profit per Employee of Vcanbio Cell & Gene Engineering Corp is 48,812.71 CNY in 2025.

Profit per Employee of Vcanbio Cell & Gene Engineering Corp changed from 43,032.64 CNY to 48,812.71 CNY, representing a 13.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Vcanbio Cell & Gene Engineering Corp

All Key Metrics — Vcanbio Cell & Gene Engineering Corp